MedPath

The Chinese University of Hong Kong

The Chinese University of Hong Kong logo
🇨🇳China
Ownership
Private
Established
1963-01-01
Employees
-
Market Cap
-
Website
http://www.cuhk.edu.hk

Evaluate Misoprostol for the Healing of Small Bowel Ulcers in Low-dose Aspirin Users Complicated by Small Bowel Bleeding

Phase 2
Completed
Conditions
Ulcer Hemorrhage
Interventions
Drug: Placebo
First Posted Date
2013-12-02
Last Posted Date
2019-01-31
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
82
Registration Number
NCT01998776
Locations
🇯🇵

Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan

🇨🇳

Prince of Wales Hospital, Hong Kong, China

The Effect of Taking Break During Colonoscopy Session on Adenoma Detection, a Prospective, Randomized Control Study

Not Applicable
Completed
Conditions
Colonic Adenoma
Interventions
Other: Break
Other: No break
First Posted Date
2013-11-21
Last Posted Date
2015-02-16
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
1379
Registration Number
NCT01989650
Locations
🇭🇰

Alice Ho Miu Ling Nethersole Hospital, Hong Kong, Hong Kong

Predictors of Colonoscopy Non-attendance and the Efficacy of a SMS Reminder to Reduce Non-attendance Rate

Not Applicable
Completed
Conditions
Ultilization of Out-patient Colonoscopy Service
Interventions
Other: SMS reminder
Other: Non-SMS reminder
First Posted Date
2013-11-15
Last Posted Date
2020-04-09
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
2225
Registration Number
NCT01984918
Locations
🇭🇰

Alice Ho Miu Ling Nethersole Hospital, Hong Kong, Hong Kong

Colon Neoadjuvant FOLFOXIRI Study

Phase 2
Active, not recruiting
Conditions
Rectal Cancer
Interventions
Drug: neoadjuvant FOLFOXIRI
First Posted Date
2013-09-13
Last Posted Date
2024-06-24
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
40
Registration Number
NCT01941641
Locations
🇭🇰

Department of Clinical Oncology, Hong Kong, Hong Kong

ATOM_local Ablative Therapy

Phase 2
Completed
Conditions
Activating EGFR Mutation
NSCLC
Interventions
Radiation: preemptive local ablative therapy
Drug: Oral TKI
First Posted Date
2013-09-13
Last Posted Date
2020-06-18
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
18
Registration Number
NCT01941654
Locations
🇭🇰

Department of Clinical Oncology, Hong Kong, Hong Kong

Safety & Effectiveness of Nurse Performed Colonoscopies Under Supervision

Not Applicable
Completed
Conditions
Colorectal Cancer
Interventions
Procedure: Colonoscopy
First Posted Date
2013-08-15
Last Posted Date
2013-08-15
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
731
Registration Number
NCT01923155
Locations
🇭🇰

Combined Endoscopy Unit, Alice Ho Miu Ling Nethersole Hospital, Tai Po, Hong Kong

A Randomized Controlled Trial on the Efficacy of Tenofovir Disoproxil Fumarate (TDF)-Switch Therapy in Chronic Hepatitis B Patients With Incomplete Response to Entecavir

Not Applicable
Completed
Conditions
Chronic Heptitis B
Interventions
First Posted Date
2013-08-08
Last Posted Date
2017-07-19
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
36
Registration Number
NCT01918631
Locations
🇭🇰

Prince of Wales Hospital, Hong Kong, Hong Kong

Impact of Sleep Education Program on Glycemic Control in Hong Kong Chinese Type 2 Diabetic Patients

Not Applicable
Conditions
Type 2 Diabetes Mellitus
Interventions
Behavioral: Sleep education
First Posted Date
2013-06-20
Last Posted Date
2013-06-20
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
264
Registration Number
NCT01881724
Locations
🇭🇰

Clinical Trial Centre, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, Hong Kong

🇨🇳

The Chinese University of Hong Kong, Hong Kong, China

Electroacupuncture for Postoperative Ileus After Laparoscopic Rectal Cancer Surgery

Not Applicable
Conditions
Postoperative Ileus
Interventions
Procedure: Electroacupuncture
First Posted Date
2013-05-03
Last Posted Date
2014-02-11
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
50
Registration Number
NCT01844908
Locations
🇨🇳

Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China

Transarterial Ethanol Ablation(TEA) for Unresectable Hepatocellular Carcinoma(HCC)

Not Applicable
Completed
Conditions
Hepatocellular Carcinoma
Interventions
Procedure: TEA
First Posted Date
2013-04-23
Last Posted Date
2019-09-03
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
200
Registration Number
NCT01837381
Locations
🇭🇰

Department of Clinicl Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, Hong Kong

🇭🇰

Department of Imaging and Interventional Radiology, Prince of Wales Hospital, The Chinsese University of Hong Kong, Hong Kong, Hong Kong

🇭🇰

Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath